+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Urinary Tract Infection Market by Clinical Indication (Cystitis, Pyelonephritis, Urethritis), Treatment (Diagnosis, Therapatics), End User - Forecast 2024-2030- Product Image
Global Urinary Tract Infection Market by Clinical Indication (Cystitis, Pyelonephritis, Urethritis), Treatment (Diagnosis, Therapatics), End User - Forecast 2024-2030- Product Image
Sale

Global Urinary Tract Infection Market by Clinical Indication (Cystitis, Pyelonephritis, Urethritis), Treatment (Diagnosis, Therapatics), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4986010
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Urinary Tract Infection Market size was estimated at USD 11.67 billion in 2023, USD 12.47 billion in 2024, and is expected to grow at a CAGR of 6.93% to reach USD 18.67 billion by 2030.

A urinary tract infection, commonly termed a UTI, refers to a bacterial infection that affects any section of the urinary system, including the kidneys, ureters, bladder, and urethra. Most bacterial infections involve the lower urinary tract, which includes the bladder and the urethra. Women are at higher risk of developing a UTI than men due to their anatomy. If left untreated, a UTI can lead to more severe complications, including kidney damage. The market's scope encompasses antibiotic treatments, pain management medications, diagnostics tests (urine culture and sensitivity tests), medical devices (urinary catheters), and preventive solutions (prophylactic antibiotics for recurrent UTIs).

A growth in the aging population and increasing incidences of conditions that are associated with a higher risk of developing UTIs, such as diabetes and kidney stones, has created an urgent need for UTI diagnostics and therapeutics. However, limitations with the sensitivity and accuracy of diagnostics procedures and the increasing prevalence of multi-drug resistant UTI pathogens raise concerns about the reliability and efficacy of urinary tract infection diagnostics and treatment strategies. However, key players are developing new antimicrobial agents with novel mechanisms of action to combat antibiotic resistance. Moreover, enhancing diagnostics with rapid, at-home, or point-of-care testing solutions to enable timely and accurate detection and management of UTIs is also gaining traction. Emerging trends also include the adoption of telemedicine consultations and digital health platforms aimed at UTI management and prevention.

Regional Insights

The Americas region, particularly the U.S. and Canada, leads in the UTI market in terms of research, diagnostic developments, and innovative treatments. The high prevalence of UTIs, coupled with strong healthcare infrastructure and patient awareness, drives the need for advanced diagnostics and therapeutic UTI procedures. Significant investments in biotechnology firms focusing on next-generation antibiotics and non-antibiotic approaches have been observed. Recent patents in the U.S. involve novel diagnostic methods and advanced drug delivery systems aimed at improving patient outcomes and reducing recurrence rates. EU countries exhibit diverse market dynamics due to varying healthcare policies and access.

However, a common trend is the increasing research funding for antimicrobial resistance and the development of new treatment methods. The EU's commitment to combat antibiotic-resistant infections includes significant investment in research and innovation projects targeting UTIs. Moreover, the adoption of telemedicine and e-health services is enhancing patient accessibility to care for UTIs. Furthermore, the presence of stringent regulations pertaining to the development of clinical diagnostics and therapeutic devices has created a standardized landscape for the development and progress of UTI diagnostics and treatment solutions. APAC's UTI market is characterized by high demand for affordable treatments and increasing awareness. The growth is facilitated by government healthcare initiatives and a booming generic pharmaceuticals sector. Research in countries such as Japan, China, and India often focuses on herbal and alternative medicines for UTI treatment, catering to consumer preferences for non-chemical alternatives.

Market Trends by Segment

  • Clinical Indication: Need for potent and advanced medication strategies for the management of pyelonephritis
  • End User: Recent advancements to improve self-administration solutions through the proliferation of telemedicine and e-health platforms

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Vivoo launches at-home digital UTI test at CES 2024

Vivoo launched its advanced, at-home digital urinary tract infection (UTI) testing solution at CES 2024. This product advanced UTI testing by offering a quick, two-minute process that integrates seamlessly with the Vivoo app. Users simply conduct the test using a urine strip, scan it with their smartphone, and instantly receive results through the app. The Vivoo’s UTI test leverages advanced deep learning image processing technology to provide precision, aiming to achieve high accuracy while facilitating a streamlined experience for users.

NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical entity, announced that the U.S. Food and Drug Administration (FDA) has officially cleared its Investigational New Drug (IND) Application for NRX-101, showcasing an advanced use in the realm of complicated urinary tract infections (cUTI). NRX-101, an innovative combination of D-cycloserine and lurasidone, stands out due to NRx's unique discovery. This combination effectively mitigates the central nervous system (CNS) side effects associated with treatment, positioning NRX-101 as a significant patented antibiotic solution.

Intron enters collaboration with the US Army on bacteriophages for urinary tract infections

Intron Biotechnology Inc. successfully secured a contract with the U.S. Army Combat Capabilities Development Command (DEVCOM). This collaboration is set to propel the development of innovative bacteriophage therapies targeted at neutralizing uropathogenic Escherichia coli (UPEC), a prevalent cause of urinary tract infections (UTIs). The initiative falls under the department of the U.S. Army Futures Command, signifying an effort to mitigate the incidence of UTIs among soldiers operating in challenging conditions, including deployment zones and training environments.

Key Company Profiles

The report delves into recent significant developments in the Urinary Tract Infection Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla Limited, Dr. Reddys Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shionogi & Co., Ltd., Siemens Healthcare AG, Sun Pharmaceutical Industries Limited, Sysmex Corporation, Teva Pharmaceutical Industries Ltd., URIT Medical Electronic Co., Ltd., and Viatris Inc.

This research report offers invaluable insights into various crucial aspects of the Urinary Tract Infection Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Diabetes and Kidney Stones
5.1.1.2. High Incidences of UTI in Female Population
5.1.1.3. Complicated UTI due to Rise in Excessive Use of Antibiotics and Drug-Resistance
5.1.2. Restraints
5.1.2.1. Adverse Effects of Urinary Tract Infection Treatment Drugs such as Aminoglycosides and Azoles
5.1.3. Opportunities
5.1.3.1. Rise in R&D for a Novel Class of Antibiotics, Vaccines, and Devices
5.1.3.2. Increase in Awareness among People and Healthcare Expenditure
5.1.4. Challenges
5.1.4.1. Social Stigma Concerning Urinary Tract Infections
5.2. Market Segmentation Analysis
5.2.1. Clinical Indication: Need for potent and advanced medication strategies for the management of pyelonephritis
5.2.2. End User: Recent advancements to improve self-administration solutions through the proliferation of telemedicine and e-health platforms
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Urinary Tract Infection Market, by Clinical Indication
6.1. Introduction
6.2. Cystitis
6.3. Pyelonephritis
6.4. Urethritis
7. Urinary Tract Infection Market, by Treatment
7.1. Introduction
7.2. Diagnosis
7.3. Therapatics
8. Urinary Tract Infection Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Self-Administered
9. Americas Urinary Tract Infection Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Urinary Tract Infection Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Urinary Tract Infection Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Vivoo launches at-home digital UTI test at CES 2024
12.3.2. NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections
12.3.3. Intron enters collaboration with the US Army on bacteriophages for urinary tract infections
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. URINARY TRACT INFECTION MARKET RESEARCH PROCESS
FIGURE 2. URINARY TRACT INFECTION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. URINARY TRACT INFECTION MARKET DYNAMICS
FIGURE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. URINARY TRACT INFECTION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. URINARY TRACT INFECTION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. URINARY TRACT INFECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AZOLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AZOLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY QUINOLONES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY QUINOLONES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ?-LACTAM, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ?-LACTAM, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 63. CANADA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 64. CANADA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 65. CANADA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 66. CANADA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 67. CANADA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 68. CANADA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 69. CANADA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 70. CANADA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 71. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 72. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 73. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 74. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 75. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 76. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 77. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 78. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 107. CHINA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 108. CHINA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 109. CHINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 110. CHINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 111. CHINA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 112. CHINA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 113. CHINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 114. CHINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 115. INDIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 116. INDIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 117. INDIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 118. INDIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 119. INDIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 120. INDIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 121. INDIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 122. INDIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 131. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 132. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 133. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 134. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 135. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 136. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 137. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 179. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 180. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 181. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 182. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 183. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 184. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 185. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 186. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 205. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 206. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 207. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 208. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 209. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 210. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 211. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 214. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 215. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 216. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 217. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 218. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 219. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 220. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 221. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 222. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 223. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 224. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 225. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 226. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 227. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 228. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 229. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 230. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 231. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 232. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 233. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 234. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 235. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 236. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 237. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 238. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 239. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 240. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 241. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 242. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 243. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 244. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 253. ITALY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 254. ITALY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 255. ITALY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 256. ITALY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 257. ITALY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 258. ITALY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 259. ITALY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 260. ITALY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 277. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 278. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 279. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 280. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 281. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 282. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 283. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 284. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 285. POLAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 286. POLAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 287. POLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 288. POLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 289. POLAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 290. POLAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 291. POLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 292. POLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 293. QATAR URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 294. QATAR URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 295. QATAR URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 296. QATAR URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 297. QATAR URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 298. QATAR URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 299. QATAR URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 300. QATAR URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 325. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 326. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 327. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 328. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 329. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2023 (USD MILLION)
TABLE 330. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2024-2030 (USD MILLION)
TABLE 331. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 332. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN URINARY

Companies Mentioned

  • AbbVie Inc.
  • Almirall, S.A.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr. Reddys Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shionogi & Co., Ltd.
  • Siemens Healthcare AG
  • Sun Pharmaceutical Industries Limited
  • Sysmex Corporation
  • Teva Pharmaceutical Industries Ltd.
  • URIT Medical Electronic Co., Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 12.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.67 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Global Urinary Tract Infection Treatment Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Image

Global Urinary Tract Infection Treatment Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • 200 Pages
  • Global
From
Complicated Urinary Tract Infections Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Complicated Urinary Tract Infections Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 238 Pages
  • Global
From
Global Urinary Tract Infection Therapeutics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Urinary Tract Infection Therapeutics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 172 Pages
  • Global
From
Urinary Tract Infection Treatment Global Market Report 2024 - Product Image

Urinary Tract Infection Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Complicated Urinary Tract Infections - Epidemiology Forecast - 2034 - Product Image

Complicated Urinary Tract Infections - Epidemiology Forecast - 2034

  • Report
  • 119 Pages
  • Global
From

About the Urinary Tract Infection Drug Market

The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs. The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.